Mr. Shane Bohnen's most recent trade in Bio-Techne Corp was a trade of 18,432 Restricted Stock Units done . Disclosure was reported to the exchange on Aug. 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 17 Aug 2026 | 18,432 | 18,432 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 17 Aug 2026 | 11,344 | 11,344 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2026 | 12,117 | 807 | - | - | Performance Stock Option (Right to Buy) | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2026 | 4,502 | 0 | - | - | Performance Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2026 | 4,350 | 11,703 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2026 | 2,332 | 4,664 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2026 | 1,669 | 1,669 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.40 per share. | 15 Aug 2026 | 1,343 | 10,360 (0%) | 0% | 72.4 | 97,233 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2026 | 300 | 4,502 | - | - | Performance Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2026 | 49 | 0 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.60 per share. | 23 Jul 2026 | 448 | 7,697 (0%) | 0% | 47.6 | 21,325 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 23 Jul 2026 | 448 | 0 | - | - | Stock Option (Right to Buy) | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.77 per share. | 23 Jul 2026 | 344 | 7,353 (0%) | 0% | 71.8 | 24,689 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.60 per share. | 05 May 2026 | 8,400 | 14,304 (0%) | 0% | 47.6 | 399,840 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 05 May 2026 | 8,400 | 448 | - | - | Stock Option (Right to Buy) | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.68 per share. | 05 May 2026 | 7,055 | 7,249 (0%) | 0% | 56.7 | 399,877 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2026 | 2,259 | 6,644 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 03 Apr 2026 | 2,259 | 0 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.13 per share. | 03 Apr 2026 | 740 | 5,904 (0%) | 0% | 53.1 | 39,316 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2025 | 17,897 | 17,897 | - | - | Stock Option (Right to Buy) | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2025 | 13,992 | 13,992 | - | - | Performance Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2025 | 6,996 | 6,996 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 1,718 | 4,912 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2025 | 1,668 | 3,338 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.60 per share. | 15 Aug 2025 | 527 | 4,385 (0%) | 0% | 53.6 | 28,247 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2025 | 50 | 49 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 2,260 | 3,941 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 03 Apr 2025 | 2,260 | 2,259 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.86 per share. | 03 Apr 2025 | 747 | 3,194 (0%) | 0% | 54.9 | 40,980 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2024 | 13,488 | 13,488 | - | - | Stock Option (Right to Buy) | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2024 | 10,012 | 10,012 | - | - | Performance Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2024 | 5,006 | 5,006 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 49 | 1,696 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2024 | 49 | 99 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.93 per share. | 15 Aug 2024 | 15 | 1,681 (0%) | 0% | 74.9 | 1,124 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 03 Apr 2024 | 2,259 | 4,519 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 2,259 | 2,394 (0%) | 0% | - | Common Stock | |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.87 per share. | 03 Apr 2024 | 747 | 1,647 (0%) | 0% | 67.9 | 50,699 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2023 | 16,302 | 16,302 | - | - | Stock Option (Right to Buy) | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2023 | 12,924 | 12,924 | - | - | Stock Option (Right to Buy) | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2023 | 4,802 | 4,802 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 15 Aug 2023 | 148 | 148 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 03 Apr 2023 | 6,778 | 6,778 | - | - | Restricted Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 03 Apr 2023 | 3,928 | 3,928 | - | - | Stock Option (right to buy) |